<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" orientation="portrait" position="float">
 <label>Table 1.
  <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml"> </span>
 </label>
 <caption>
  <title>SARS-CoV-2, SARS-CoV and MERS-CoV diagnose systematic assessment results.</title>
 </caption>
 <!--OASIS TABLE HERE-->
 <table frame="hsides" rules="groups">
  <colgroup>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
  </colgroup>
  <thead valign="top">
   <tr>
    <th align="left">Viral strain</th>
    <th align="left">Test</th>
    <th align="left">Samples</th>
    <th align="left">References</th>
    <th align="left">Ref.</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td align="left">SARS-CoV-2</td>
    <td align="left">rRT-PCR; E gene assay; confirmatory testing: RdRp gene assay</td>
    <td align="left">Respiratory samples from hospitalized patients</td>
    <td align="left"> </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B33">33</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">SARS-CoV-2</td>
    <td align="left">COVID-19 IgG/IgM rapid test kit</td>
    <td align="left">Saliva swab samples</td>
    <td align="left">Commercial kit from myLAB Box</td>
    <td align="left"> </td>
   </tr>
   <tr>
    <td align="left">SARS-CoV-2</td>
    <td align="left">A colorimetric assay based on gold nanoparticles</td>
    <td align="left">Saliva swab</td>
    <td align="left">Oxford Suzhou Centre for Advanced Research (OSCAR)</td>
    <td align="left"> </td>
   </tr>
   <tr>
    <td align="left">SARS-CoV-2</td>
    <td align="left">A colorimetric assay based on gold nanoparticles coated with glycans</td>
    <td align="left">Saliva swab</td>
    <td align="left">Iceni Diagnostics</td>
    <td align="left"> </td>
   </tr>
   <tr>
    <td align="left">MERS-CoV</td>
    <td align="left">A collection of six separate, industrial, MERS CoV RNA detection kits focused on the PCR-RRT: (i) PowerChek (Kogene Biotech, Korea); (ii) DiaPlexQ (SolGent, Korea); (iii) Anyplex (Seegene), Korea) Screening: envelope gene (upE) Confirmation: ORF1a (iv) AccuPower (Bions, Korean) (v)</td>
    <td align="left">28 swabs alert for the other air viruses nasopharyngeal</td>
    <td align="left"> </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B34">34</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">MERS-CoV</td>
    <td align="left">Loopamp RNA Amplification Kit (RT-LAMP)</td>
    <td align="left">Laboratory isolates MERS-CoV swabs from healthy adults</td>
    <td align="left"> </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B35">35</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">MERS-CoV</td>
    <td align="left">A one-step rRT-PCR assay, based on specific TaqMan</td>
    <td align="left">Synthesis of UpE and ORF1b</td>
    <td align="left"> </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B36">36</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">SARS-CoV</td>
    <td align="left">Real-time qRT-PCR; ELISA technique</td>
    <td align="left">Samples obtained from 40-SARS hospitalized patients in Hong Kong</td>
    <td align="left"> </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B37">37</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">SARS-CoV</td>
    <td align="left">Enhanced RT-fluorescent PCR</td>
    <td align="left">Samples obtained from 80-SARS hospitalized patients in Hong Kong</td>
    <td align="left"> </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B38">38</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">SARS-CoV</td>
    <td align="left">Quantitative, RT and, nested PCR</td>
    <td align="left">Samples obtained from 46-SARS hospitalized patients from Taiwan</td>
    <td align="left"> </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B39">39</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">SARS-CoV</td>
    <td align="left">Western blot assay with N195 protein</td>
    <td align="left">274 clinical sera collected from patients with probable or suspected SARS, dengue fever, autoimmune diseases</td>
    <td align="left"> </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B40">40</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">SARS-CoV</td>
    <td align="left">RT-PCR</td>
    <td align="left">274 clinical sera collected from Hong Kong</td>
    <td align="left"> </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B41">41</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
